Piramal Pharma’s US facility gets EIR from FDA

Piramal Pharma

Piramal Pharma, Pharmaceutical major on Tuesday said the United States Food and Drug Administration (US FDA) has concluded its inspection of Sellersville, US-based manufacturing facility. The company revealed that the US FDA issued an EIR for its Sellersville manufacturing facility. The inspection was conducted between December 19, 2022, and January 13, 2023.